ADMA Deadline Alert: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. (ADMA) Investors of Securities Class Action Deadline on August 10, 2026

ADMA Biologics allegedly used channel stuffing to inflate ASCENIV revenues by millions, turning reported 20% growth into an estimated 3% decline, according to a new securities class action. NEW YORK, July 22, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ADMA Biologics,...